Cardiac Positron Emission Tomography

• I. Methodology.- 1. Trends in Instrumentation.- 2. Attenuation Correction: Practical Considerations.- 3. Radiopharmaceuticals.- 4. Utility and Limitations of [18F]2-Deoxy-2-Fluoro-D-Glucose for the Assessment of Flux Through Metabolic Pathways in Heart Muscle: A Critical Appraisal.- 5. Quantitative Evaluation of Myocardial Perfusion.- II. Myocardial Perfusion Imaging.- 6. Assessment of Myocardial Perfusion with 13N-Ammonia or 82Rb.- 7. Assessment of Myocardial Perfusion with 15O-Water.- 8. 62Cu-PTSM: A Generator-Based Radiopharmaceutical for Myocardial Perfusion Imaging.- 9. Comparison of Cost-Effectiveness of Myocardial Perfusion Imaging Versus Other Approaches: Predictions by a Model.- III. Assessment of Tissue Viability.- 10. Assessment of Blood Flow and Substrate Metabolism in the Myocardium of the Normal Human Heart.- 11. Comparison of SPECT and PET for Assessment of Tissue Viability.- 12. 11C-Acetate in the Study of Ischemic Heart Disease.- 13. Assessment of Myocardial Viability using 15O-Water.- 14. Myocardial 82Rb Kinetics Identify Cell Membrane Integrity and Tissue Viability.- 15. Imaging Hypoxic Myocardium.- IV. Other Applications.- 16. Quantification of Myocardial Oxygen Consumption using 11C-Acetate.- 17. Applications in Nonischemic Heart Disease and Heart Failure.- 18. Use of PET Radiopharmaceuticals to Probe Cardiac Receptors.- V. Appendix.- 19. Clinical PET Protocols.

'... this book is highly recommendable for everybody involved in CPET. It is also a readable source of information not only to nuclear medicine physicists but also to cardiologists, cardiac surgeons, physiologists and clinical physicists and radiopharmacists. This book should gain widespread acceptance... The scientific accuracy is undoubtedly high; the quality of written contributions is perfect, as is the quality of all presented figures; there is also a chapter on color display.' European Journal of Nuclear Medicine, 24:2 (1997)